Stay updated on Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Site revision label updated from v3.4.3 to v3.5.0. This appears to be a minor version update with no substantive changes to the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-03-25T20:16:31.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    - Added a Resources entry linking to the Genetic and Rare Diseases Information Center for Malignant Pleural Mesothelioma.
    Difference
    0.2%
    Check dated 2026-03-18T13:47:53.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T11:16:28.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Site update adds Revision: v3.4.2 and removes the prior funding notice and Revision: v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-11T01:40:50.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    A government funding notice banner was added and the page revision tag updated to v3.4.1, while the previous revision tag v3.4.0 was removed.
    Difference
    0.5%
    Check dated 2026-02-04T00:00:38.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated QC-related labels to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', with the revision indicator updated to v3.4.0. The older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.
    Difference
    0.2%
    Check dated 2026-01-27T23:59:10.000Z thumbnail image

Stay in the know with updates to Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page.